463 related articles for article (PubMed ID: 33115994)
1. [Ictal electroencephalography (EEG) activity and cerebral blood flow dynamics as potential pathological indicators: a case of anti-leucine-rich glioma-inactivated 1 protein (LGI1) encephalitis].
Ishibashi H; Neshige S; Aoki S; Ueno H; Iida K; Maruyama H
Rinsho Shinkeigaku; 2020 Nov; 60(11):778-785. PubMed ID: 33115994
[TBL] [Abstract][Full Text] [Related]
2. Seizure semiology in leucine-rich glioma-inactivated protein 1 antibody-associated limbic encephalitis.
Chen C; Wang X; Zhang C; Cui T; Shi WX; Guan HZ; Ren HT; Shao XQ
Epilepsy Behav; 2017 Dec; 77():90-95. PubMed ID: 29050866
[TBL] [Abstract][Full Text] [Related]
3. A case of pediatric anti-leucine-rich glioma inactivated 1 encephalitis with faciobrachial dystonic seizure.
Jang S; Kim SY; Kim WJ; Chae JH; Kim KJ; Lim BC
Brain Dev; 2023 Jun; 45(6):348-353. PubMed ID: 36858863
[TBL] [Abstract][Full Text] [Related]
4. Clinical analysis of leucine-rich glioma inactivated-1 protein antibody associated with limbic encephalitis onset with seizures.
Li Z; Cui T; Shi W; Wang Q
Medicine (Baltimore); 2016 Jul; 95(28):e4244. PubMed ID: 27428233
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of nine cases of leucine-rich glioma inactivated 1 protein antibody-associated encephalitis.
Li Y; Song F; Liu W; Wang Y
Acta Neurol Belg; 2021 Aug; 121(4):889-897. PubMed ID: 32232701
[TBL] [Abstract][Full Text] [Related]
6. Clinical features of 28 cases of anti
Feng J; Li J; Xie Y; Lü Y; Bi F; Zhou J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):386-396. PubMed ID: 37164922
[TBL] [Abstract][Full Text] [Related]
7. [A case of smoldering anti-leucine-rich glioma-inactivated 1 (LGI1) antibody-associated limbic encephalitis with faciobrachial dystonic seizure].
Nakaoku Y; Maki T; Kanazawa K; Matsumoto R; Fukuyama H; Takahashi R; Ikeda A
Rinsho Shinkeigaku; 2013; 53(9):706-11. PubMed ID: 24097318
[TBL] [Abstract][Full Text] [Related]
8. Anti-leucine-rich Glioma-inactivated-1 Encephalitis with Faciobrachial Dystonic Seizures and Behavioral Problems: A Case Report.
Adhikari A; Subedi RC; Acharya S; Paudel R
JNMA J Nepal Med Assoc; 2020 Jul; 58(227):487-490. PubMed ID: 32827010
[TBL] [Abstract][Full Text] [Related]
9. [Ictal EEG pattern of transient epileptic amnesia in acute phase of non-herpetic limbic encephalitis].
Chiba T; Henmi N; Neshige S; Takada K; Ikeda A; Takahashi R; Yokoe M
Rinsho Shinkeigaku; 2020 Jun; 60(6):446-451. PubMed ID: 32435050
[TBL] [Abstract][Full Text] [Related]
10. Electroencephalographic findings in antileucine-rich glioma-inactivated 1 (LGI1) autoimmune encephalitis: A systematic review.
Roberto KT; Espiritu AI; Fernandez MLL; Gutierrez JC
Epilepsy Behav; 2020 Nov; 112():107462. PubMed ID: 32971385
[TBL] [Abstract][Full Text] [Related]
11. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis.
Irani SR; Michell AW; Lang B; Pettingill P; Waters P; Johnson MR; Schott JM; Armstrong RJ; S Zagami A; Bleasel A; Somerville ER; Smith SM; Vincent A
Ann Neurol; 2011 May; 69(5):892-900. PubMed ID: 21416487
[TBL] [Abstract][Full Text] [Related]
12. Bi-Basal Ganglia Involvement with Signal Evolution in a Case of Anti-LGI1 Encephalitis.
Gai Q; Ruan S; Dong X; Cong S
Neurol India; 2022; 70(1):384-386. PubMed ID: 35263922
[TBL] [Abstract][Full Text] [Related]
13. Clinical diagnosis of LGI1 antibody encephalitis in an 83-year-old woman.
Attwood JE; Naseer S; Michael S; Riley J
BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33431450
[TBL] [Abstract][Full Text] [Related]
14. Clinical features of patients with anti-leucine-rich glioma inactivated-1 protein associated encephalitis: a Chinese case series.
Yang X; Li AN; Zhao XH; Liu XW; Wang SJ
Int J Neurosci; 2019 Aug; 129(8):754-761. PubMed ID: 30621547
[No Abstract] [Full Text] [Related]
15. Efficacy of rituximab on seizure control and cognitive symptoms in leucine-rich, glioma-inactivated 1 (LGI1) limbic encephalitis: a high-density electroencephalography case study.
Cheli M; Dinoto A; Tommasini V; Ajčević M; Stella G; Catalan M; Stokelj D; Sartori A; Manganotti P
Epileptic Disord; 2020 Oct; 22(5):678-682. PubMed ID: 33146142
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study.
Li W; Wu S; Meng Q; Zhang X; Guo Y; Cong L; Cong S; Zheng D
BMC Neurol; 2018 Jul; 18(1):96. PubMed ID: 29980179
[TBL] [Abstract][Full Text] [Related]
17. Clinical Features, Immunotherapy, and Outcomes of Anti-Leucine-Rich Glioma-Inactivated-1 Encephalitis.
Huang X; Fan C; Gao L; Li L; Ye J; Shen H
J Neuropsychiatry Clin Neurosci; 2022; 34(2):141-148. PubMed ID: 34794327
[TBL] [Abstract][Full Text] [Related]
18. Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype.
Irani SR; Stagg CJ; Schott JM; Rosenthal CR; Schneider SA; Pettingill P; Pettingill R; Waters P; Thomas A; Voets NL; Cardoso MJ; Cash DM; Manning EN; Lang B; Smith SJ; Vincent A; Johnson MR
Brain; 2013 Oct; 136(Pt 10):3151-62. PubMed ID: 24014519
[TBL] [Abstract][Full Text] [Related]
19. Clinical features of anti-leucine-rich glioma-inactivated 1 encephalitis in northeast China.
Zhao Q; Sun L; Zhao D; Chen Y; Li M; Lu Y; Li G; Lin W
Clin Neurol Neurosurg; 2021 Apr; 203():106542. PubMed ID: 33706063
[TBL] [Abstract][Full Text] [Related]
20. Anti-LGI1 encephalitis causing faciobrachial dystonic seizures.
Zouras S; Stephens JW; Abburu SR; Emelle C
BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29103007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
